SEC Form 4 · accession 0001179110-17-011725
MADRIGAL PHARMACEUTICALS, INC. · MDGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard S Levy
Director
Period of report
Aug 21, 2017
Accepted (ET)
Aug 22, 2017 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157601
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 21, 2017 | P | 900 | $15.67 | A | 900 | D | |
| Common Stock | Aug 21, 2017 | P | 100 | $15.70 | A | 1,000 | D | |
| Common Stock | Aug 21, 2017 | P | 100 | $15.72 | A | 1,100 | D | |
| Common Stock | Aug 21, 2017 | P | 200 | $15.77 | A | 1,300 | D | |
| Common Stock | Aug 21, 2017 | P | 200 | $15.79 | A | 1,500 | D | |
| Common Stock | Aug 21, 2017 | P | 400 | $15.80 | A | 1,900 | D | |
| Common Stock | Aug 21, 2017 | P | 10 | $15.90 | A | 1,910 | D | |
| Common Stock | Aug 21, 2017 | P | 200 | $15.93 | A | 2,110 | D | |
| Common Stock | Aug 21, 2017 | P | 200 | $16.02 | A | 2,310 | D | |
| Common Stock | Aug 21, 2017 | P | 210 | $16.04 | A | 2,520 | D | |
| Common Stock | Aug 21, 2017 | P | 440 | $16.07 | A | 2,960 | D | |
| Common Stock | Aug 21, 2017 | P | 590 | $16.09 | A | 3,550 | D |
Table II — derivative securities
No Table II lines on this filing.